BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT03099161-completion@plaintrial.com
DTSTAMP:20261029T044839Z
DTSTART;VALUE=DATE:20180221
SUMMARY:Study of Preladenant (MK-3814) Alone and With Pembrolizumab (MK-347
 5) in Participants With Advanced Solid Tumors (MK-3814A-062) — estimated
  completion date
DESCRIPTION:Terminated. Saved on your PlainTrial shortlist. Full trial reco
 rd: https://plaintrial.com/trial/NCT03099161
URL:https://plaintrial.com/trial/NCT03099161
END:VEVENT
END:VCALENDAR